← Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Press Releases
Date | Press release |
---|---|
2025-04-22 06:43:00 | Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue And Adjusted Diluted Eps Guidance For Full Year 2025 First quarter revenues of $2.65 billion, up 12.1% from 2024 first quarter reported diluted earnings per share (\"eps\") of $1.94, up 12.8% from 2024; and adjusted diluted eps of $2.21, up 8.3% from 2024 full year 2025 reported diluted eps now expected to be between $8.62 and $8.87; and adjusted diluted eps is expected to remain between $9.55 and $9.80 secaucus, n.j. , april 22, 2025 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), a leading provider of diagnostic information services, today announced financial results for the first quarter ended march 31, 2025. |
2025-04-09 07:53:00 | Quest Diagnostics Launches New Ad-detect™ Blood Test To Aid In Confirming Alzheimer’s Disease In an oral presentation at the 2025 aan annual meeting, quest scientists presented data suggesting the test can accurately assess alzheimer’s disease pathology with greater than 90% sensitivity and specificity secaucus, n.j. , april 9, 2025 /prnewswire/ -- quest diagnostics (nyse: dgx), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to alzheimer’s disease (ad) in patients with mild cognitive impairment (mci) or dementia. |
2025-04-02 07:06:00 | Quest Diagnostics Introduces Hpv Specimen Self-collection For Cervical Cancer Screening Providers in the united states may now order the fda-cleared hpv self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to screening by enabling discreet self-collection quest also plans to make self-collection option available at its 2,000 patient service centers in the united states early next month, expanding access to screening new solution follows company’s launch of gti self-collection option for several stis and related conditions last fall secaucus, n.j. , april 2, 2025 /prnewswire/ -- quest diagnostics (nyse: dgx), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (hpv) screening to help identify women who are at risk of developing cervical cancer. |
2025-04-01 16:23:00 | Quest Diagnostics To Release First Quarter 2025 Financial Results On April 22, 2025 Secaucus, n.j. , april 1, 2025 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), a leader in diagnostic information services, announced that it will report first quarter 2025 financial results on tuesday, april 22, 2025, before the market opens. |
2025-03-19 07:52:00 | Quest Diagnostics To Highlight Strategic Priorities To Drive Sustainable Growth And Deliver Long-term Shareholder Value At 2025 Investor Day Provides long-term outlook beyond 2025: revenues expected to grow at 4-5% compound annual growth rate (cagr); adjusted diluted earnings per share (eps) expected to grow at 7-9% cagr reaffirms guidance for full year 2025 secaucus, n.j. , march 19, 2025 /prnewswire/ -- at a meeting with analysts and investors at its 2025 investor day, members of the leadership team of quest diagnostics (nyse: dgx), a leading provider of diagnostic information services, will discuss the company’s strategies to drive sustainable growth and deliver long-term shareholder value. |
2025-03-18 09:00:00 |
|
2025-02-24 08:00:00 |
|
2025-02-13 16:54:00 |
|
2025-02-12 09:00:00 |
|
2025-01-30 16:14:00 |
|
2025-01-30 06:45:00 |
|
2025-01-27 08:56:00 |
|
2025-01-08 08:42:00 |
|
2025-01-02 11:00:00 |
|
2024-12-03 09:50:00 |
|
